文献速递先天性心脏病外科瓣膜外科

3D打印患者特异性无细胞纳米纤维组织工程血管移植物的羊模型临床前研究

Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.
PubMed 文献 · J Thorac Cardiovasc Surg · 2016-11-14

本研究探索结合3D打印与静电纺丝技术制作患者特异性组织工程血管移植物(TEVG)的可行性。基于羊胸段下腔静脉术前影像设计并3D打印静电纺丝芯轴,在芯轴上电纺TEVG支架,将6例患者特异性无细胞TEVG植入羊模型作为下腔静脉间置 conduits,6个月后取出进行组织学、生化和生物力学评估。结果显示所有羊存活无并发症,移植物均通畅,无动脉瘤形成或异位钙化;系列血管造影显示3至6个月间TEVG压力梯度显著下降;取出时纳米纤维支架几乎完全吸收,TEVG机械性能与自体下腔静脉相似,组织学显示有序平滑肌细胞层、细胞外基质沉积和内皮化,弹性蛋白和胶原含量与自体下腔静脉无显著差异,壁厚度与CD68+巨噬细胞浸润显著正相关。结论认为该技术是未来临床选项的可行技术,需进一步开展涉及更复杂解剖形状的临床前研究。

要点

  • 3D打印结合静电纺丝可制作患者特异性无细胞TEVG。
  • 羊模型6个月显示TEVG通畅、无动脉瘤或钙化,支架几乎完全吸收。
  • TEVG组织学与机械性能接近自体下腔静脉,壁厚与巨噬细胞浸润正相关。

核心结论

  • 结合静电纺丝与3D打印制作患者特异性纳米纤维TEVG是未来临床选项的可行技术。

研究设计与样本

  • 基于羊胸段下腔静脉术前影像计算机辅助设计并3D打印静电纺丝芯轴,在芯轴上电纺TEVG支架。
  • 将6例患者特异性无细胞TEVG作为下腔静脉间置 conduits 植入羊模型,6个月后取出评估。

主要发现

  • 所有羊存活无并发症,所有移植物通畅,无动脉瘤形成或异位钙化。
  • 系列血管造影显示3至6个月间TEVG压力梯度显著下降。
  • 取出时纳米纤维支架几乎完全吸收,TEVG机械性能与自体下腔静脉相似。
  • 组织学显示有序平滑肌细胞层、细胞外基质沉积和内皮化,弹性蛋白和胶原含量与自体下腔静脉无显著差异。
  • 壁厚度与CD68+巨噬细胞浸润入TEVG呈显著正相关。

关键数值与推荐

  • 6例患者特异性无细胞TEVG植入羊模型,6个月后取出评估。
  • TEVG压力梯度在3至6个月间显著下降。
  • 纳米纤维支架取出时几乎完全吸收。
  • TEVG与自体下腔静脉的弹性蛋白和胶原含量无显著差异。
  • 壁厚度与CD68+巨噬细胞浸润显著正相关。

临床怎么用

  • 该技术有望为先天性心脏病重建提供患者特异性可降解支架。
  • 当前结果支持进一步开展更复杂解剖形状的临床前研究。

局限性

  • 需进一步开展涉及更复杂解剖形状的临床前研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tissue-engineered vascular grafts (TEVGs) offer potential to overcome limitations of current approaches for reconstruction in congenital heart disease by providing biodegradable scaffolds on which autologous cells proliferate and provide physiologic functionality. However, current TEVGs do not address the diverse anatomic requirements of individual patients. This study explores the feasibility of creating patient-specific TEVGs by combining 3-dimensional (3D) printing and electrospinning technology. METHODS: An electrospinning mandrel was 3D-printed after computer-aided design based on preoperative imaging of the ovine thoracic inferior vena cava (IVC). TEVG scaffolds were then electrospun around the 3D-printed mandrel. Six patient-specific TEVGs were implanted as cell-free IVC interposition conduits in a sheep model and explanted after 6 months for histologic, biochemical, and biomechanical evaluation. RESULTS: All sheep survived without complications, and all grafts were patent without aneurysm formation or ectopic calcification. Serial angiography revealed significant decreases in TEVG pressure gradients between 3 and 6 months as the grafts remodeled. At explant, the nanofiber scaffold was nearly completely resorbed and the TEVG showed similar mechanical properties to that of native IVC. Histological analysis demonstrated an organized smooth muscle cell layer, extracellular matrix deposition, and endothelialization. No significant difference in elastin and collagen content between the TEVG and native IVC was identified. There was a significant positive correlation between wall thickness and CD68+ macrophage infiltration into the TEVG. CONCLUSIONS: Creation of patient-specific nanofiber TEVGs by combining electrospinning and 3D printing is a feasible technology as future clinical option. Further preclinical studies involving more complex anatomical shapes are warranted.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Fukunishi T, Best CA, Sugiura T, et al. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model. J Thorac Cardiovasc Surg. 2016. PMID: 27938900. doi:10.1016/j.jtcvs.2016.10.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。